Aphea.Bio

Aphea.Bio

Private
East FlandersHealthcare & Life Scienceshttps://www.aphea.bio

Last Round

Grant

Nov 4, 2024

Total Funding Raised

$115.31M

Momentum Score

25 /100

Company Overview

Aphea.Bio is an agricultural biotechnology company that develops innovative products to enhance crop yields and health while promoting sustainable practices in pest and disease management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biologicalsbiostimulantsbiofungicidesag biotechmicrobial productsbiocontrol productsseed treatmentsustainable agriculturechemical pesticide alternativesfoliar spraysynthetic fertilizer alternativescrop inputsbioinsecticidesbioherbicides

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aphea.Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aphea.Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantNov 4, 2024
Series CJul 11, 2023
Series B ExtensionApr 14, 2021
Series BNov 20, 2020
Series AJun 26, 2017
Grant
Jun 26, 2017

Key People

Founding team and executive leadership

Steven Vandenabeele

Co-founder Chief Technology Officer

Founding Team

Isabel Vercauteren

CEO

Executive Team

Gerald Coward

Chief Financial Officer

Executive Team

Dave Ingham

Chief Operating Officer

Executive Team

Aphea.Bio Investors

Notable investors and investment history

InvestorRounds
Gemma Frisius FundSeries B, Series B Extension
Agri Investment FundSeries C, Series B, Series B Extension, Series A
Federal Holding and Investment CompanySeries C
Astanor VenturesSeries C, Series B Extension, Series B
KorysSeries C
ECBFSeries C, Series B Extension
KU LeuvenSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 11, 2023

    $77M round completed.

Aphea.Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aphea.Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aphea.Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersEast Flanders
Employee Range70
Year Founded2017
Last FundingNov 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.